[ALA] YoY Quarter Result on 30-Sep-2019 [#Q1]

Stock
[ALA] Arovella Therapeutics Limited
Announcement Date
29-Sep-2019
Financial Year
2020
Quarter
30-Sep-2019 [#Q1]
Profit Trend
QoQ- 44.40%
YoY- -785.06%
Quarter Report
ALA's Result
ALA's Financial Summary
View:
Show?
Quarter Result
30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 CAGR
Revenue 714 11 176 192 427 202 195 24.13%
PBT -1,950 -1,975 -874 -3,850 -435 -1,113 -527 24.35%
Tax 0 0 0 0 0 0 56 -
NP -1,950 -1,975 -874 -3,850 -435 -1,113 -471 26.70%
Tax Rate - - - - - - - -
Total Cost 2,664 1,986 1,050 4,041 862 1,315 666 25.97%
Ratio Analysis
30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 CAGR
NP Margin -272.98 -17,484.01 -496.92 -2,008.97 -101.83 -551.87 -240.94 2.10%
Per Share
30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 CAGR
EPS -0.00 -0.00 -0.00 -0.03 -0.00 -0.02 -0.01 -
EPS Diluted -0.00 -0.00 -0.00 -0.03 -0.00 -0.02 -0.01 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.